Comparative Pharmacology
Head-to-head clinical analysis: FERRLECIT versus IRON DEXTRAN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FERRLECIT versus IRON DEXTRAN.
FERRLECIT vs IRON DEXTRAN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ferric carboxymaltose, a polynuclear iron(III)-hydroxide carbohydrate complex, provides a source of iron for hemoglobin synthesis and erythropoiesis. The iron is released to endogenous iron transport proteins, such as transferrin, and stored as ferritin or hemosiderin.
Iron dextran is a colloidal solution of ferric oxyhydroxide complexed with dextran, which provides a source of iron for hemoglobin synthesis. After intramuscular or intravenous administration, the iron-dextran complex is taken up by the reticuloendothelial system, where iron is released and bound to transferrin for erythropoiesis.
125 mg elemental iron (5 mL) intravenously over 1-5 minutes or as infusion over 15-30 minutes, repeated as needed based on iron deficiency.
IM or IV: Calculate total iron deficit using formula: Body weight (kg) × (target Hb - actual Hb) × 0.24 + 500 mg (for iron stores). Administer as single IV infusion or daily IM doses up to 2 mL (100 mg) per day. IV infusion: Dilute in 0.9% NaCl and infuse over 1-6 hours; test dose of 25 mg recommended.
None Documented
None Documented
Sodium ferric gluconate has a terminal half-life of approximately 1 hour for the intact complex. However, after dissociation, iron is rapidly cleared from plasma with a half-life of about 6 hours. The clinical context: the short half-life minimizes free iron toxicity but requires frequent dosing for iron replacement.
The terminal elimination half-life is approximately 5-6 hours for the iron-dextran complex, but the iron released from the complex has a half-life of 2-3 days due to incorporation into erythrocytes and storage pools.
Iron is not excreted renally; elimination is primarily through fecal loss of unabsorbed iron (approximately 80-90% of orally administered iron) and minor desquamation of mucosal cells. After IV administration, iron is incorporated into hemoglobin and storage pools; minimal urinary excretion (<1%). Biliary excretion of iron is negligible.
Iron dextran is primarily excreted via the reticuloendothelial system; iron is incorporated into hemoglobin and stored as ferritin/ hemosiderin. Renal excretion of intact complexes is minimal (<1%). Fecal excretion accounts for less than 1% of the dose.
Category C
Category C
Iron Replacement
Iron Replacement